ArticleJournal for immunotherapy of cancer2017

Retrospective review of safety and efficacy of programmed cell death-1 inhibitors in refractory high grade gliomas.

Samantha N Reiss et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.